Home/Pipeline/Alzheimer's program

Alzheimer's program

Alzheimer's Disease

Clinical (China & US)Active

Key Facts

Indication

Alzheimer's Disease

Phase

Clinical (China & US)

Status

Active

Company

Risen Pharma Tech

About Risen Pharma Tech

Clinical-stage biotech developing small molecule and siRNA drugs for osteoarthritis, oncology, and Alzheimer's disease with international competitiveness.

View full company profile

Therapeutic Areas

Orthopedics Oncology Neuroscience

Other Alzheimer's Disease Drugs

Drug	Company	Phase	Status
NUZ-001	Neurizon Therapeutics	Preclinical	Active
ALZN002	Alzamend Neuro	Preclinical	Research
P021	Phanes Biotech	Preclinical	Active
PB43D	Phanes Biotech	Preclinical	Active
UB-311	Vaxxinity	Phase 2	Active
Lecanemab	BioArctic	Launched	Active (Commercial)
BAN2401	BioArctic	Preclinical	Active
Undisclosed Programs	Johnson and Johnson Innovative Medicine	Pipeline	Active
MK-6240 (florquinitau)	Lantheus Medical Imaging	Regulatory Filing	Filed
NAV-4694 (flutafuranol)	Lantheus Medical Imaging	Phase 3	Active
LNTH-2620/PI-2620	Lantheus Medical Imaging	Phase 3	Recruiting
itMSCs	Stemedica Cell Technologies	Clinical Development	Active